Metabolic effects of short-term reproduction of the normal diurnal cortisol rhythm in hypopituitary adults

Endocrinology and Metabolism, Supplement

Volumn 4, Issue 3, 1997, Pages 207-214

  Al Shoumer, Kamal A S ^a   Anyaoku, Victor ^a   Ali, Kamsiah ^a   Johnston, Desmond G ^a  

^a NONE   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; CORTICOTROPIN; FATTY ACID; GLUCOSE; GLYCEROL; GROWTH HORMONE; HYDROCORTISONE; INSULIN;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN DEFICIENCY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOPITUITARISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY;

EID: 0030813181     PISSN: 1074939X     EISSN: 20935978     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Weitzman ED, Fukushima D, Nogeire H, Roffwarg H, Gallagher TF, Hellman L. Twenty-four hour pattern of episodic secretion of Cortisol in normal subjects. J. Clin. Endocrinol. 1970; 33: 14-22.
2. Krieger DT, Allen W, Rizza F, Krieger HP. Characterisation of the normal temporal pattern of plasma corticosteroid levels. J. Clin. Endocrinol. 1971; 32: 266-284.
3. Kehlet H, Binder CHR, Blichert-Toft M. Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation. Clin. Endocrinol. Oxford 1976; 5: 37-41.
4. Scott RS, Donald RA, Espiner EA. Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy. Clin. Endocrinol. Oxford 1978;9:571-576.
5. Al-Shoumer KAS, Ali K, Anyaoku V, Niththyananthan R, Johnston DG. Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clin. Endocrinol. Oxford 1996; 45: 171-178.
6. Hampton SM, Morgan LM, Tredger JA, Cramb R, Marks V. Insulin and C-peptide levels after oral and intravenous glucose. Diabetes 1986; 35: 612-616.
7. Teale JD, Marks V. The measurement of insulin like growth factor I: clinical applications and significance. Ann. Clin. Biochem. 1986; 23: 413-424.
8. Van Cauter E, Blackman JD, Ronald D, Spire J-P, Refetoff S, Polonsky KS. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J. Clin. Invest. 1991; 88: 934-942.
9. Simmons PS, Miles JM, Gerich JE, Haymond MW. Increased Proteolysis: an effect of increases in plasma cortisol within the physiologic range. J. Clin. Invest. 1984; 73: 412-420.
10. Divertie GD, Jensen MD, Miles JM. Stimulation of lipolysis in humans by physiological hypercortisolemia. Diabetes 1991; 40: 1228-1232.
11. Dinneen S, Alzaid A, Miles J, Rizza R. Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. J. Clin. Invest. 1993; 92: 2283-2290.
12. Issekutz B, Borkow I. Effect of catecholamines and dibutyryl-cyclic-AMP on glucose turnover, plasma free fatty acids, and insulin in dogs treated with methylprednisolone. Canad. J. Physiol. Pharm. 1972; 50: 999-1006.
13. Tanaka H, Ichikawa Y, Akama H, Homma M. In vivo responsiveness to glucocorticoid correlated with glucocorticoid receptor content in peripheral blood leukocytes in normal humans. Acta Endocrinol. 1989; 121(Suppl.): 470-476.
14. Owen OE, Cahill GF. Metabolic effects of exogenous glucocorticoids in fasted man. J. Clin. Invest. 1973; 52: 2596-2605.
15. Saunders J, Hall SE, Sönksen PM. Glucose and free fatty acid turnover in Cushing's syndrome. J. Endocrinol. Invest. 1980; 3: 309-311.
16. Miyoshi H, Shulman GI, Peters EJ, Wolfe MH, Elahi D, Wolfe RR. Hormonal control of substrate cycling in humans. J. Clin. Invest. 1988; 81: 1545-1555.
17. Birkenhäger JC, Timmermans HAT, Lamberts SWJ. Depressed plasma FFA turnover rate in Cushing's syndrome. J. Clin. Endocrinol. Metab. 1976; 42: 28-32.
18. Horber F, Marsh HM, Haymond MW. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes 1991; 40: 141-149.
19. Van Cauter E, Aschoff J. Endocrine and other biological rhythms. In: DeGroot LJ, editor. Endocrinology. Philadelphia: W. B. Saunders, 1989: 2658-2705.
20. Rizza R, Mandarine L, Gerich J. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilisation due to post-receptor defect of insulin action. J. Clin. Endocrinol. Metab. 1982; 54: 131-138.
21. Brasel JA, Wright JC, Wilkins L, Blizzard RM. An evaluation of 75 patients with hypopituitarism beginning in childhood. Amer. J. Med. 1965; 38: 484-498.
22. Goodman HG, Grumbach MM, Kaplan SL. Growth and growth hormone. II. a comparison of isolated growth hormone deficiency and multiple pituitary hormone deficiencies in 35 patients with idiopathic hypopituitary dwarfism. N. Engl. J. Med. 1968; 278: 57-68.
23. Hopwood NJ, Forsman PJ, Kenney FM, Drash AL. Hypoglycemia in hypopituitary children. Amer. J. Dis. Child. 1975; 129: 918-929.
24. Boyle PJ, Cryer PE. Growth hormone, cortisol, or both are involved in defence against, but are not critical to recovery from, hypoglycemia. Amer. J. Physiol. 1991; 260: E395-E402.
25. Van Cauter E, Polonsky KS, Blackman JD, Ronald D, Sturis J, Byrne MM, Scheen AJ. Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone secretion and circadian cortisol rhythmicity. J. Clin. Endocrinol. Metab. 1994; 79: 1797-1805.